Biotech · Private company · San Diego, CA, US
Regulus Therapeutics Inc.
SEC CIK 0001505512
Track this companyFree. Adds Regulus Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- RGLS4326Phase 1 · Polycystic Kidney Disease, Autosomal DominantClinicalTrials.gov · fetched Nov 12, 2026
- RGLS8429Phase 1 · Autosomal Dominant Polycystic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RGLS8429Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney DiseasePHASE1 · COMPLETED · started Oct 6, 2022ClinicalTrials.gov NCT05521191 · fetched Nov 12, 2026
- A Study of RGLS8429 in Healthy VolunteersPHASE1 · COMPLETED · started Jun 10, 2022ClinicalTrials.gov NCT05429073 · fetched Nov 12, 2026
- A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney DiseasePHASE1 · COMPLETED · started Oct 13, 2020ClinicalTrials.gov NCT04536688 · fetched Nov 12, 2026
SEC filings9
- 8-K · FORM 8-KSEC EDGAR · filed Jun 25, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 8, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 8, 2025 · fetched Nov 12, 2026
- 10-K/A · 10-K/ASEC EDGAR · filed Apr 30, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 27, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 13, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 13, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 4, 2025 · fetched Nov 12, 2026